1. Home
  2. SNFCA vs VYGR Comparison

SNFCA vs VYGR Comparison

Compare SNFCA & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Security National Financial Corporation

SNFCA

Security National Financial Corporation

HOLD

Current Price

$9.30

Market Cap

234.1M

Sector

Finance

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$4.00

Market Cap

232.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNFCA
VYGR
Founded
1965
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.1M
232.4M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
SNFCA
VYGR
Price
$9.30
$4.00
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$17.00
AVG Volume (30 Days)
33.8K
467.1K
Earning Date
11-13-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.74
N/A
Revenue
$340,876,482.00
$31,316,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$71.78
P/E Ratio
$12.34
N/A
Revenue Growth
3.25
N/A
52 Week Low
$7.32
$2.65
52 Week High
$12.83
$6.37

Technical Indicators

Market Signals
Indicator
SNFCA
VYGR
Relative Strength Index (RSI) 57.30 40.94
Support Level $8.84 $4.24
Resistance Level $9.46 $4.58
Average True Range (ATR) 0.31 0.24
MACD 0.03 -0.01
Stochastic Oscillator 50.00 31.36

Price Performance

Historical Comparison
SNFCA
VYGR

About SNFCA Security National Financial Corporation

Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: